These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15824419)

  • 1. Antigenic and phenotypic modifications of Yersinia pestis under calcium and glucose concentrations simulating the mammalian bloodstream environment.
    Feodorova VA; Golova AB
    J Med Microbiol; 2005 May; 54(Pt 5):435-441. PubMed ID: 15824419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extracellular resistance of Yersinia pestis to phagocytosis].
    Fedorova VA; Golova AB
    Vestn Ross Akad Med Nauk; 2005; (10):19-25. PubMed ID: 16320702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast and simple detection of Yersinia pestis applicable to field investigation of plague foci.
    Simon S; Demeure C; Lamourette P; Filali S; Plaisance M; Créminon C; Volland H; Carniel E
    PLoS One; 2013; 8(1):e54947. PubMed ID: 23383008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of acid-stable proteins and modified lipopolysaccharide of Yersinia pestis in acidic growth medium.
    Feodorova VA; Devdariani ZL
    J Med Microbiol; 2001 Nov; 50(11):979-985. PubMed ID: 11699595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic characterization of Yersinia pestis virulence.
    Chromy BA; Choi MW; Murphy GA; Gonzales AD; Corzett CH; Chang BC; Fitch JP; McCutchen-Maloney SL
    J Bacteriol; 2005 Dec; 187(23):8172-80. PubMed ID: 16291690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague.
    Guinet F; Avé P; Filali S; Huon C; Savin C; Huerre M; Fiette L; Carniel E
    PLoS Pathog; 2015 Oct; 11(10):e1005222. PubMed ID: 26484539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic profiling of yersinia pestis infection in the Wyoming coyote (Canis latrans).
    Vernati G; Edwards WH; Rocke TE; Little SF; Andrews GP
    J Wildl Dis; 2011 Jan; 47(1):21-9. PubMed ID: 21269993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic and coagulative activities of Yersinia pestis.
    Korhonen TK; Haiko J; Laakkonen L; Järvinen HM; Westerlund-Wikström B
    Front Cell Infect Microbiol; 2013; 3():35. PubMed ID: 23898467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092.
    Welkos SL; Friedlander AM; Davis KJ
    Microb Pathog; 1997 Oct; 23(4):211-23. PubMed ID: 9344782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-induced changes in the lipopolysaccharide of Yersinia pestis affect plasminogen activation by the pla surface protease.
    Suomalainen M; Lobo LA; Brandenburg K; Lindner B; Virkola R; Knirel YA; Anisimov AP; Holst O; Korhonen TK
    Infect Immun; 2010 Jun; 78(6):2644-52. PubMed ID: 20368351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of Glucose Activates Catabolite Repression during Pneumonic Plague.
    Ritzert JT; Lathem WW
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29555700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.
    Feodorova VA; Pan'kina LN; Savostina EP; Kuznetsov OS; Konnov NP; Sayapina LV; Dentovskaya SV; Shaikhutdinova RZ; Ageev SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP; Motin VL
    Vaccine; 2009 Apr; 27(16):2240-50. PubMed ID: 19428838
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Smiley ST; Szaba FM; Kummer LW; Duso DK; Lin JS
    Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30804102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix.
    Lähteenmäki K; Virkola R; Sarén A; Emödy L; Korhonen TK
    Infect Immun; 1998 Dec; 66(12):5755-62. PubMed ID: 9826351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of
    Dudte SC; Hinnebusch BJ; Shannon JG
    Front Cell Infect Microbiol; 2017; 7():358. PubMed ID: 28848716
    [No Abstract]   [Full Text] [Related]  

  • 16. [Levels of fraction I and VW antigens in cultures of the plague microbe grown on yeast-casein, yeast-Hottinger broth and yeast-sunflower oil cake media].
    Sheremet OV; Terent'ev AN; Shatova IN; Morozova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):18-22. PubMed ID: 2442925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenicity of Yersinia pestis grown on nutrient media at 28 and 37 degrees C].
    Sheremet OV; Miliutin VN; Terent'ev AN; Morozova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):63-8. PubMed ID: 3673377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rapid diagnostic test for plague detects Yersinia pestis F1 antigen in ancient human remains].
    Bianucci R; Rahalison L; Ferroglio E; Massa ER; Signoli M
    C R Biol; 2007 Oct; 330(10):747-54. PubMed ID: 17905394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.
    Welkos S; Pitt ML; Martinez M; Friedlander A; Vogel P; Tammariello R
    Vaccine; 2002 May; 20(17-18):2206-14. PubMed ID: 12009274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antigen biosynthesis during the limitation of Yersinia pestis growth].
    Krivachenko KB
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):86-8. PubMed ID: 10876906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.